|
FY2021
10 months to Dec 31, 2021
|
|
|---|---|
| Cash flows from Operating Activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Formation costs paid by related party | |
| Interest income on cash and marketable securities held in Trust Account | |
| Changes in current assets and current liabilities: | |
| Prepaid assets | |
| Accrued offering costs and expenses | |
| Net cash used in operating activities | |
| Cash flows from Investing Activities: | |
| Investment held in Trust Account | |
| Net cash used in investment activities | |
| Cash flows from Financing Activities: | |
| Proceeds from issuance of Founder Shares | |
| Proceeds from initial public offering, net of underwriters' discount | |
| Proceeds from private placement warrants | |
| Proceeds from issuance of promissory note to related party | |
| Payment of deferred offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash, end of the period | |
| Supplemental disclosure of noncash investing and financing activities: | |
| Excess fair value of representative Founder Shares | |
| Deferred offering costs paid through issuance of promissory note | |
| Initial classification of common stock subject to possible redemption | |
| Accretion of Class A subject to possible redemption |
Loading...
